Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day
Shares of Inovio Pharmaceuticals Inc. INO, +4.20% rose 4.20% to $0.39 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA, +1.47% rising 1.47% to 35,950.89 and the NASDAQ Composite Index COMP, -0.23% falling 0.23% to 14,226.22.
The stock's rise snapped a three-day losing streak.
Inovio Pharmaceuticals Inc. closed $1.61 short of its 52-week high ($2.00), which the company reached on December 1st.
The stock outperformed some of its competitors Thursday, as Johnson & Johnson JNJ, +1.68% rose 1.68% to $154.66, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. PFE, +1.30% rose 1.30% to $30.47.
Trading volume (2.4 M) remained 1.3 million below its 50-day average volume of 3.7 M.
Editor's Note: This story was auto-generated by Automated Insights , an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
